Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

APOL1 polymorphism modulates sphingolipid profile of human podocytes

Glycoconjugate Journal(2020)10.1007/s10719-020-09944-wSource: DataRank Database

APOL1 polymorphism modulates sphingolipid profile of human podocytes is a research paper published in Glycoconjugate Journal (2020). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

Linked data & code

refsnp

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.51)OA: hybridTopics (70)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Valentina Cazzetta ORCID,Ferdinando Oriolo ORCID,Xiqian Lan,Rocco Piazza ORCID,Moin A. Saleem ORCID

Live enrichment

PubMed:32915357 PMC:PMC7679335 OpenAlex:https://openalex.org/W3086246061

Foundation for the National Institutes of Health

Grant: RO1DK118017

NIDDK NIH HHS

Grant: R01 DK118017

National Institutes of Health

Grant: 1R01DK118017-01

APOL1 in Diabetic Podocytopathy

FWCI

0.51

Citation Percentile

0.6%

Citation Trend

2020

2022

2023

2024

2025

hybridLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s10719-020-09944-w.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s10719-020-09944-w.pdf

publisherhttps://link.springer.com/article/10.1007/s10719-020-09944-w/fulltext.html

journalhttps://doi.org/10.1007/s10719-020-09944-w

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32915357

Fields of Study

Renal Diseases and GlomerulopathiesSphingolipid Metabolism and SignalingChronic Lymphocytic Leukemia Research0301 basic medicine03 medical and health sciences0303 health sciencesApolipoprotein L1Cell MembraneGene Expression RegulationGlycoside HydrolasesHumansMetabolismPodocytesPolymorphism, GeneticSphingolipids

MeSH Terms

Apolipoprotein L1Cell MembraneGene Expression RegulationGlycoside HydrolasesHumansMetabolismPolymorphism, GeneticSphingolipidsPodocytes

Keywords

LactosylceramideSphingolipidGlobotriaosylceramideGlycosphingolipidSphingomyelinCeramideSphingosineBiochemistryChemistryLipidomicsBiologyLipid raftCell biologyCellGlycolipidReceptorMembraneInternal medicineFabry diseasePlasma membranelipid raftsPodocytesSphingolipidsApol1HivanApol1 PolymorphismPodocytes/metabolismApolipoprotein L1/genetics570Glycoside Hydrolases610Gene Expression Regulation/geneticsAPOL1; APOL1 polymorphism; HIVAN; Lipid rafts; Plasma membrane; Podocytes; Sphingolipids;Glycoside Hydrolases/geneticsHumansPolymorphismGenetic/geneticsPolymorphism, GeneticCell MembraneCell Membrane/geneticsApolipoprotein L1MetabolismGene Expression RegulationOriginal ArticleSphingolipids/geneticsAPOL1; APOL1 polymorphism; HIVAN; Lipid rafts; Plasma membrane; Podocytes; Sphingolipids

Sustainable Development Goals

SDG 10: 10. No inequality

APOL1 polymorphism modulates sphingolipid profile of human podocytes

FAIR Checklist

Authors (10)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)